Bausch Health Companies (BHC) Revenue Growth (5y) (2014 - 2026)
Bausch Health Companies (BHC) Revenue Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.69 Bn | 380.51 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.48% |
| Dec 31, 2025 | 4.79% |
| Sep 30, 2025 | 4.63% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | 2.34% |
| Dec 31, 2024 | 2.85% |
| Sep 30, 2024 | 2.59% |
| Jun 30, 2024 | 2.23% |
| Mar 31, 2024 | 1.32% |
| Dec 31, 2023 | 2.57% |
| Sep 30, 2023 | 0.94% |
| Jun 30, 2023 | 0.36% |
| Mar 31, 2023 | -0.52% |
| Dec 31, 2022 | 0.28% |
| Sep 30, 2022 | -1.61% |
| Jun 30, 2022 | -2.50% |
| Mar 31, 2022 | -1.88% |
| Dec 31, 2021 | 24.68% |
| Sep 30, 2021 | -3.16% |
| Jun 30, 2021 | -2.80% |